In part 1 of the COPD Stakeholder Summit, a panel of experts about the burden of COPD, available treatments, and more. Today, we are bringing you part 1 of a 2-part podcast series discussing chronic ...

I’M Dr Suraj Kukadia, known as Dr Sooj, an NHS GP who has seen how life-changing COPD can be. As the colder months set in, I ...

David H. Au, MD, MS, kicked off the Hospital Readmissions session at the American Thoracic Society 2013 conference with his presentation on Defining the Role of the Practitioner, Scientist and ...

COPD is a progressive lung disease with mild symptoms in the early stages that gradually worsen. Early diagnosis and treatment can help preserve lung function. The GOLD system previously classified ...

A new study from Brazil has found that damage to the lungs in younger adults isn’t just caused by smoking. Obesity and ...

Inhaled bronchodilators can be useful in patients with COPD, even when spirometry testing before and after acute bronchodilator therapy does not show a significant (> 10%) response. [23] Long-acting ...

Pulmatrix Presents Top Line Clinical Data Showing Inhaled Drug Candidate, PUR118, Demonstrated Anti-Inflammatory Efficacy In Phase 1b Trial with COPD Patients , Inc., a clinical stage biotechnology ...

Cigarette smoking is the cause of 80%-90% of COPD in the United States. The most effective method to prevent COPD is to avoid cigarette smoking. Efforts to prevent cigarette smoking need to be ...

therapeutics is at least partially mediated through activity on macrophages. • PUR118 was clinically evaluated in an innovative Phase 1 clinical study, and the design and implementation of the Phase 1 ...